RNA Earnings

Quarterly EPS
$-0.65
Q3 2024
$-0.79
Q4 2024
$-0.90
Q1 2025
$-1.21
Q2 2025
$-1.27
Q3 2025
$-1.54
Q4 2025
$-0.97
Q1 2026
$-1.18
Q2 2026
Latest Revenue3.0M
Latest Net Income-20186000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.183.0M-20186000-21.9%+2.5%
Q1 2026-$0.9719.6M-16633000+1,148.3%-7.8%
Q4 2025-$1.54860.0K-237101000-71.1%-94.9%
Q3 2025-$1.2712.5M-174442000+434.0%-95.4%
Q2 2025-$1.213.8M-157315000+88.1%-86.2%
Q1 2025-$0.901.6M-115773000-55.6%-13.9%
Q4 2024-$0.793.0M-102257000+35.6%+0.0%
Q3 2024-$0.652.3M-80398000-17.1%+8.5%
Q2 2024-$0.652.0M-70793000
Q1 2024-$0.793.5M-68855000
Q4 2023-$0.792.2M-60443000
Q3 2023-$0.712.8M-52358000
Atrium Therapeutics (RNA) — Earnings